1.13
price up icon6.60%   0.07
after-market Handel nachbörslich: 1.10 -0.03 -2.65%
loading

Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
35.00
- - 0.09 -
Operating Expenses
25.95%
7.435
5.903 6.414 5.782 7.503
Operating Income/Loss
566.97%
27.57
-5.903 -6.414 -5.692 -7.503
Nonoperating Income/Loss
11.81%
0.336
0.381 0.474 0.561 0.625
Net Income/Loss
605.27%
27.90
-5.522 -5.94 -5.131 -6.878
Basic Average Shares
0.52%
31.40
31.24 - 31.20 31.20
Diluted Average Shares
0.54%
31.41
31.24 - 31.20 31.20
Basic Earnings Per Share
594.44%
0.89
-0.18 - -0.16 -0.22
Diluted Earnings Per Share
594.44%
0.89
-0.18 - -0.16 -0.22
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Kapitalisierung:     |  Volumen (24h):